Adaptimmune stock plunges after announcing Nasdaq delisting plans
Dayforce, Inc. (NASDAQ:DAY) Executive Vice President, CLO, & Secretary William Everett McDonald, sold 1,912 shares of common stock on October 15, 2025, at a price of $68.25, for a total value of $130494.
Following the transaction, McDonald directly owns 101,772 shares of Dayforce, Inc. With the company’s earnings report scheduled for October 29, 2025, InvestingPro subscribers can access comprehensive insider trading analysis and 12+ additional investment insights about Dayforce.
The sale was executed under a Rule 10b5-1 trading plan adopted on August 15, 2024. The company currently trades at elevated multiples compared to its peers, reflecting market expectations for continued growth. In other recent news, Dayforce Inc. has been at the center of significant developments following its acquisition by Thoma Bravo. The acquisition deal values Dayforce at $12.3 billion, with the company set to go private at $70 per share, offering a 32% premium over its previous share price. This transaction is expected to close in early 2026, pending shareholder and regulatory approval. In connection with the acquisition, a $5.5 billion leveraged loan has been launched by a consortium of banks led by Goldman Sachs to support the financing of the deal. Analysts have reacted to the acquisition news with several downgrades. Stifel downgraded Dayforce’s stock from Buy to Hold, adjusting the price target to $70.00 from $72.00. Similarly, Mizuho downgraded the stock from Outperform to Neutral, lowering its price target from $80.00 to $70.00. BMO Capital also downgraded Dayforce to Market Perform but raised its price target to $70.00 from $67.00. These downgrades reflect the market’s assessment of the acquisition’s impact on Dayforce’s stock value. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.